#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15114	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2029	737.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1458	1458	C	871	C	834	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	735.7	0	.	n	.	0	T695C	SNP	695	695	T	1086	1086	C	818	C	778	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	735.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1728	1728	A	983	A	934	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	735.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2362	2362	C	842	C	794	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	735.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2436	2436	A	819	A	775	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3692	735.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2988	2988	C	806	C	763	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2034	folP	852	852	100.0	folP.l15.c30.ctg.1	1564	129.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1044	1046	AGC	226;225;228	A;G;C	213;214;214	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5500	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3284	166.5	1	SNP	p	S91F	0	.	.	271	273	TCC	548	550	TCC	203;202;204	T;C;C	183;185;184	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5500	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3284	166.5	1	SNP	p	D95N	0	.	.	283	285	GAC	560	562	GAC	195;192;195	G;A;C	179;177;183	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5500	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3284	166.5	1	SNP	p	D95G	0	.	.	283	285	GAC	560	562	GAC	195;192;195	G;A;C	179;177;183	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1746	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1466	118.9	0	.	p	.	0	A39T	NONSYN	115	117	GCC	543	545	ACC	185;184;182	A;C;C	158;169;164	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1746	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1466	118.9	0	.	p	.	0	R44H	NONSYN	130	132	CGC	558	560	CAC	182;185;184	C;A;C	167;169;171	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1746	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1466	118.9	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	741	743	CAC	219;219;216	C,T;A;C	209,1;209;208	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	539	1746	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1466	118.9	1	SNP	p	G45D	0	.	.	133	135	GGC	561	563	GGC	182;184;184	G;G;C	170;167;170	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	868	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1008	85.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2849	191.2	1	SNP	p	D86N	0	.	.	256	258	GAC	531	533	GAC	225;226;227	G;A;C	214;211;212	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2849	191.2	1	SNP	p	S87R	0	.	.	259	261	AGT	534	536	AGT	226;227;226	A,C;G;T	209,2;214;208	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2849	191.2	1	SNP	p	S87I	0	.	.	259	261	AGT	534	536	AGT	226;227;226	A,C;G;T	209,2;214;208	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2849	191.2	1	SNP	p	S87W	0	.	.	259	261	AGT	534	536	AGT	226;227;226	A,C;G;T	209,2;214;208	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5478	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2849	191.2	1	SNP	p	S88P	0	.	.	262	264	TCC	537	539	TCC	230;232;230	T;C;C	212;216;214	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4532	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2630	171.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1541	1543	GGC	199;197;195	G;G;C	188;185;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1288	1290	GCA	202;201;200	G,A;C;A	186,1;186;190	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1291	1293	ATC	196;196;200	A;T;C	185;185;188	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1303	1305	GTG	210;211;210	G;T;G	195;197;197	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1303	1305	GTG	210;211;210	G;T;G	195;197;197	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1807	1809	ACC	211;206;205	A;C;C	194;193;196	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1861	1863	GCG	212;208;207	G,C;C;G	184,1;164;170	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1861	1863	GCG	212;208;207	G,C;C;G	184,1;164;170	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1984	1986	GGC	179;182;181	G;G;C	166;168;168	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1993	1995	GGC	173;172;173	G;G;C	158;160;161	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4026	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2300	173.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2011	2013	CCG	140;146;145	C,G;C;G	110,5;116;112	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5956	ponA	2397	2397	99.96	ponA.l15.c30.ctg.1	3132	189.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2350	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1584	146.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	466	466	C	179	C	163	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	E48G	NONSYN	142	144	GAA	626	628	GGA	280;281;281	G;G;A	270;268;269	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	T132A	NONSYN	394	396	ACC	878	880	GCC	245;243;241	G;C;C,G	227;227;217,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	F135L	NONSYN	403	405	TTT	887	889	CTT	246;250;248	C;T;T	233;237;235	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	911	913	GGA	230;229;226	G;G;A	218;218;213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	D171G	NONSYN	511	513	GAT	995	997	GGT	244;244;247	G;G;T	230;231;227	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1049	1051	AGC	250;251;252	A;G;C,T	240;240;235,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1115	1115	T	241	T	229	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	1	SNP	p	G120K	0	.	.	358	360	GGT	842	844	GGT	276;274;270	G,A;G,A;T,G	260,1;260,1;243,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	1	SNP	p	A121N	0	.	.	361	363	GCC	845	847	GCC	268;266;268	G,A;C,A;C	246,1;251,1;250	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3176	porB1b	1035	1035	94.92	porB1b.l15.c30.ctg.1	1671	188.1	1	SNP	p	A121D	0	.	.	361	363	GCC	845	847	GCC	268;266;268	G,A;C,A;C	246,1;251,1;250	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11284	rpoB	4179	4179	100.0	rpoB.l6.c30.ctg.1	4822	233.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1911	1913	AAT	253;254;251	A,C;A;T	238,1;237;234	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1230	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1062	114.9	1	SNP	p	V57M	1	.	.	169	171	ATG	512	514	ATG	237;235;237	A;T;G	220;219;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
